SCHEMBL2629501

SCHEMBL2629501

CC(C)(C)N1CCC2(CCN(c3ccccc3)CC2)C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ USP2 O75604 7/20 0.51
▸ CYP2D6 P10635 4/20 0.51
▸ CYP2C9 P11712 4/20 0.50
▸ GRIN2D O15399 1/20 0.49
▸ GRIN3B O60391 1/20 0.49
▸ CHRM2 P08172 1/20 0.49
▸ CHRM1 P11229 1/20 0.49
▸ OPRM1 P35372 1/20 0.49
▸ GRIN1 Q05586 1/20 0.49
▸ KCNH2 Q12809 1/20 0.49
▸ GRIN2A Q12879 1/20 0.49
▸ GRIN2B Q13224 1/20 0.49
▸ GRIN2C Q14957 1/20 0.49
▸ GRIN3A Q8TCU5 1/20 0.49
▸ CYP3A4 P08684 9/20 0.47
▸ CYP2C19 P33261 7/20 0.47
▸ MAPK1 P28482 5/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ ALDH1A1 P00352 8/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2629500 0.92 CYP3A4 (0.52) USP2CYP2D6CYP2C9GRIN2DGRIN3B
SCHEMBL2629499 0.90 GRIN2D (0.53) USP2CYP2D6CYP2C9GRIN2DGRIN3B
SCHEMBL2629498 0.90 USP2 (0.59) USP2CYP2D6CYP2C9GRIN2DGRIN3B
SCHEMBL11947818 0.84 CYP2C9 (0.52) CYP2D6CYP2C9CYP3A4CYP2C19MAPK1
SCHEMBL11947827 0.84 ALDH1A1 (0.42) MAPK1MEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL11947821 0.84 HTR3E (0.42) MEN1KMT2AALDH1A1SMN1; SMN2HPGD
SCHEMBL11947823 0.82 CHRNB2 (0.50) CHRNB2CHRNA3CHRNA7CHRNA4
SCHEMBL13131047 0.81 HTR3E (0.47) USP2CYP2D6CYP2C9CYP3A4CYP2C19
SCHEMBL11947830 0.81 CA12 (0.41) USP2CYP2D6CYP2C9CYP3A4CYP1A2
SCHEMBL13131049 0.80 KDM4E (0.46) USP2CYP2D6KCNH2SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 — — US disclosed
US-8492559-B2 Substituted indole compounds GRUENENTHAL GMBH (DE) 2013-07-23 — — US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 — — US disclosed
US-8357717-B2 Spiro group-containing amide compounds having bradykinin 1 receptor (B1R) activity GRUENENTHAL GMBH (DE) 2013-01-22 — — US disclosed
US-8269000-B2 Substituted pyrimidine and triazine compounds GRUENENTHAL GMBH (DE) 2012-09-18 — — US disclosed
US-8158628-B2 Sulfonylated 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine compounds and their use as pharmaceuticals GRUENENTHAL GMBH (DE) 2012-04-17 — — US disclosed
US-8119805-B2 Substituted disulfonamide compounds GRUENENTHAL GMBH (DE) 2012-02-21 — — US disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 — — US disclosed
US-20100234387-A1 Sulfonylated Tetrahydroazolopyrazines and their Use as Pharmaceuticals GRUENETHAL GMBH (DE) 2010-09-16 — — US disclosed
US-20100234340-A1 Substituted Spiroamide Compounds GRUENENTHAL GMBH (DE) 2010-09-16 — — US disclosed
US-20100222324-A1 Substituted Indole Compounds GRUENENTHAL GMBH (DE) 2010-09-02 — — US disclosed
US-20100173889-A1 Substituted Pyrimidine and Triazine Compounds GRUENENTHAL GMBH (DE) 2010-07-08 — — US disclosed
US-20100152158-A1 Substituted Disulfonamide Compounds GRUENENTHAL GMBH (DE) 2010-06-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN USP2 4864/4885CYP2D6 1926/4885CYP2C9 2259/4885
US-20100152158-A1 Substituted Disulfonamide Compounds BDKRB1, BDKRB2, BRS3 USP2 3131/4885CYP2D6 1247/4885CYP2C9 671/4885
US-20100222324-A1 Substituted Indole Compounds BDKRB1, BDKRB2, EDNRB USP2 4568/4885CYP2D6 585/4885CYP2C9 499/4885
US-20100234387-A1 Sulfonylated Tetrahydroazolopyrazines and their Use as Pharmaceuticals BDKRB1, BDKRB2, KCNB1 USP2 4083/4885CYP2D6 721/4885CYP2C9 320/4885
US-20100173889-A1 Substituted Pyrimidine and Triazine Compounds ADORA2B, CCNB1, TYMS USP2 4431/4885CYP2D6 1157/4885CYP2C9 242/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN USP2 4864/4885CYP2D6 1926/4885CYP2C9 2259/4885
US-20100234340-A1 Substituted Spiroamide Compounds BDKRB1, BDKRB2, AVPR1B USP2 4772/4885CYP2D6 950/4885CYP2C9 351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback